Security National Bank of SO Dak Sells 353 Shares of Thermo Fisher Scientific Inc. (TMO)

Security National Bank of SO Dak reduced its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,357 shares of the medical research company’s stock after selling 353 shares during the period. Thermo Fisher Scientific comprises about 3.1% of Security National Bank of SO Dak’s holdings, making the stock its 2nd largest holding. Security National Bank of SO Dak’s holdings in Thermo Fisher Scientific were worth $2,716,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Capital Research Global Investors raised its stake in shares of Thermo Fisher Scientific by 29.8% in the second quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock valued at $3,019,185,000 after acquiring an additional 3,973,136 shares in the last quarter. Janus Henderson Group PLC raised its stake in shares of Thermo Fisher Scientific by 2,058.1% in the second quarter. Janus Henderson Group PLC now owns 2,342,046 shares of the medical research company’s stock valued at $408,620,000 after acquiring an additional 2,233,522 shares in the last quarter. Veritas Asset Management LLP raised its stake in shares of Thermo Fisher Scientific by 112.4% in the second quarter. Veritas Asset Management LLP now owns 2,430,759 shares of the medical research company’s stock valued at $424,095,000 after acquiring an additional 1,286,259 shares in the last quarter. Harbour Capital Advisors LLC raised its stake in shares of Thermo Fisher Scientific by 18,197.5% in the second quarter. Harbour Capital Advisors LLC now owns 1,201,051 shares of the medical research company’s stock valued at $6,884,000 after acquiring an additional 1,194,487 shares in the last quarter. Finally, Meritage Group LP acquired a new stake in shares of Thermo Fisher Scientific in the third quarter valued at $201,383,000. Institutional investors and hedge funds own 86.05% of the company’s stock.

Shares of Thermo Fisher Scientific Inc. (TMO) opened at $190.02 on Friday. Thermo Fisher Scientific Inc. has a 52 week low of $139.88 and a 52 week high of $201.20. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $77,107.40, a price-to-earnings ratio of 32.26, a price-to-earnings-growth ratio of 1.76 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period last year, the firm earned $2.03 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 13.9% on a year-over-year basis. equities research analysts predict that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.19%.

In other news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the sale, the chief executive officer now owns 302,577 shares in the company, valued at $58,016,113.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.49% of the stock is owned by company insiders.

Several analysts have recently issued reports on the company. Jefferies Group reiterated a “hold” rating and issued a $195.00 price objective on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Goldman Sachs Group assumed coverage on Thermo Fisher Scientific in a research note on Tuesday, September 26th. They issued a “buy” rating and a $225.00 price objective on the stock. Barclays reiterated an “overweight” rating and issued a $215.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Monday, September 25th. Leerink Swann increased their price objective on Thermo Fisher Scientific from $190.00 to $207.00 and gave the company an “outperform” rating in a research note on Monday, October 9th. Finally, Zacks Investment Research cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, September 18th. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus price target of $205.21.

COPYRIGHT VIOLATION WARNING: “Security National Bank of SO Dak Sells 353 Shares of Thermo Fisher Scientific Inc. (TMO)” was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://www.com-unik.info/2017/12/23/security-national-bank-of-so-dak-sells-353-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit